We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.86B
AUM Growth
+$155M
Cap. Flow
-$4.62M
Cap. Flow %
-0.25%
Top 10 Hldgs %
25.53%
Holding
256
New
8
Increased
83
Reduced
147
Closed
9

Top Buys

Rank Stock Value
1
WIX icon
WIX.com
WIX
+$14.2M
2
GTLS
Chart Industries
GTLS
+$14.2M
3
ZD icon
Ziff Davis
ZD
+$7.41M
4
MTN icon
Vail Resorts
MTN
+$6.65M
5
WEX icon
WEX
WEX
+$6.06M

Top Sells

Rank Stock Value
1
LRN icon
Stride
LRN
+$19M
2
VRNA
Verona Pharma
VRNA
+$15.9M
3
RBA icon
RB Global
RBA
+$8.67M
4
TKO icon
TKO Group
TKO
+$7.05M
5
AGM icon
Federal Agricultural Mortgage
AGM
+$6.68M

Sector Composition

Rank Sector Weight
1 Healthcare 31.2%
2 Technology 28.31%
3 Industrials 18.03%
4 Communication Services 6.8%
5 Consumer Discretionary 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GTLS
26
DELISTED
Chart Industries
GTLS
$23.4M 1.26%
142,381
+96,406
+210% +$14.2M
RDWR icon
27
Radware
RDWR
$1.19B
$22.2M 1.2%
754,135
-105,580
-12% -$2.5M
ITRN icon
28
Ituran Location and Control
ITRN
$1.05B
$19.7M 1.06%
508,615
+18,698
+4% +$672K
BCRX icon
29
BioCryst Pharmaceuticals
BCRX
$2.4B
$18.5M 0.99%
2,060,280
+32,712
+2% +$305K
LMAT icon
30
LeMaitre Vascular
LMAT
$1.86B
$17.8M 0.96%
213,870
+3,248
+2% +$271K
KNSA icon
31
Kiniksa Pharmaceuticals
KNSA
$5.93B
$17.7M 0.95%
638,233
+13,688
+2% +$348K
SUPN icon
32
Supernus Pharmaceuticals
SUPN
$2.77B
$16.5M 0.89%
524,647
+8,758
+2% +$281K
MTN icon
33
Vail Resorts
MTN
$5.3B
$16.3M 0.88%
103,915
+44,776
+76% +$6.65M
TRAK icon
34
ReposiTrak
TRAK
$159M
$16.2M 0.87%
826,799
-26,218
-3% -$550K
FOLD
35
DELISTED
Amicus Therapeutics
FOLD
$15.8M 0.85%
2,760,314
+750,210
+37% +$4.84M
NGVT icon
36
Ingevity
NGVT
$2.68B
$15.8M 0.85%
365,637
+1,421
+0.4% +$54.8K
CRAI icon
37
CRA International
CRAI
$1.06B
$15.6M 0.84%
83,312
+1,821
+2% +$325K
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$5.03B
$14.4M 0.78%
669,806
-2,417
-0.4% -$44.9K
SSTK icon
39
Shutterstock
SSTK
$219M
$14.2M 0.77%
750,665
+84,317
+13% +$1.48M
NBIX icon
40
Neurocrine Biosciences
NBIX
$16.6B
$13.6M 0.73%
108,382
-1,291
-1% -$148K
NEXN
41
Nexxen International
NEXN
$607M
$13.5M 0.73%
1,293,799
+407,968
+46% +$4.15M
OZK icon
42
Bank OZK
OZK
$5.61B
$13.2M 0.71%
281,013
-2,507
-0.9% -$110K
MMS icon
43
Maximus
MMS
$3.1B
$12.9M 0.7%
184,084
-1,696
-0.9% -$119K
FC icon
44
Franklin Covey
FC
$246M
$12.2M 0.66%
533,711
+9,916
+2% +$219K
ALKS icon
45
Alkermes
ALKS
$8.25B
$12.1M 0.65%
421,885
-4,700
-1% -$140K
MIRM icon
46
Mirum Pharmaceuticals
MIRM
$6.14B
$11.8M 0.64%
231,993
-2,703
-1% -$120K
HROW icon
47
Harrow
HROW
$1.51B
$11.3M 0.61%
370,627
+74,455
+25% +$2M
GNTX icon
48
Gentex
GNTX
$5.07B
$9.82M 0.53%
446,548
-4,462
-1% -$97.5K
POOL icon
49
Pool Corp
POOL
$7.5B
$9.71M 0.52%
33,312
-399
-1% -$121K
CEVA icon
50
CEVA Inc
CEVA
$1.08B
$9.69M 0.52%
440,875
+5,397
+1% +$120K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Rice Hall James & Associates held 256 positions worth $1.86B, up 9.1% from $1.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q2 2025 filing shows 8 new, 83 increased, 147 reduced and 9 closed positions. Its largest new stake was Latham Group: 582,123 shares worth $3.71M. The largest sale was Stride, an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q2 2025 buy was Latham Group: 582,123 shares worth $3.71M.
  • Rice Hall James & Associates added most to WIX.com in Q2 2025, an estimated $14.2M increase.
  • Rice Hall James & Associates's biggest Q2 2025 reduction was Stride, cutting an estimated $19M.
  • Rice Hall James & Associates fully exited Albany International in Q2 2025, selling an estimated $3.48M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.86B portfolio in Q2 2025.
  • Rice Hall James & Associates opened 8 new positions and closed 9 in Q2 2025.
  • Rice Hall James & Associates's portfolio value rose 9.1% quarter-over-quarter to $1.86B.

Based on Rice Hall James & Associates's 13F filing for Q2 2025, filed 11 Aug 2025.